[3] 薛衛成. 介紹乳腺癌TNM分期係統[J].7版. 診斷病理學雜誌，2010，17（4）：241.
[4] 陳信義，王婧，張雅月，等. 西黃丸藥效學研究及治療腫瘤特點分析[J]. 中華中醫藥雜誌，2010，25（3）：409.
[5] 金娟，李誌鴻. 西黃丸聯合化療治療乳腺癌30例[J]. 中華中醫藥雜誌，2010，25（5）：715.
Effects of Xihuangwan in assistant treatment of patients with
advanced breast cancer
HONG Ri*， WU Yong-qiang， WU Yue
（Treatment Center of Mammary Gland Diseases， 1st Affiliated Hospital of Zhejiang University of
Traditional Chinese Medicine， Hangzhou 310006， China）
[Abstract] In order to explore the possibility of Xihuangwan （XHW）′s application in assistant therapy in patients with breast cancer， short- and long-term clinical efficacy were assesse in this study. Eighty and four patients with advanced breast cancer were selected in this study. They were divided into control group and treatment group randomly and evenly. All patients received surgical treatment followed by chemotherapy regimen composed of PTX+EPI+CTX （TEC regimen）. Treatment group received additional assistant treatment of XHW. Short-term clinical efficacy was assessed by KPS， lesion stabilizing rate and side effects in 3-month follow-up study. Long-term clinical efficacy was assessed by overall survival （OS） and free-progression survival （FPS）. KPS increased significantly after treatment in all patients （P
[Key words] Xihuangwan； advanced breast cancer； short-term effect； long-term effect
doi：10.4268/cjcmm20140633